BACKGROUND: Hepatic resection is a major surgical procedure. Data on outcomes of hepatectomy in Saudi Arabia are scarce.
H epatic resection is a widely used surgical procedure for both oncologic and non-oncologic diseases 1,2 such as tumors, intrahepatic duct calculi, hydatid disease, and abscesses. Benign neoplasms include hepatocellular adenoma, hepatic hemangioma, and focal nodular hyperplasia. Resection is a curative option for various malignancies, both primary hepatocellular carcinoma 3, 4 and metastatic hepatic tu- ment, 9 the use of portal vein embolization to ensure an adequate future liver remnant, 10 a decreased duration of preoperative chemotherapy, 11,12 optimized surgical techniques, 13 tailored multidisciplinary care, [14] [15] [16] [17] and improved management plans in the event of complications.
7 Additionally, more of these procedures are being performed at tertiary centers by specially trained hepatobiliary surgeons who have a higher level of expertise.
7 Laparoscopy has also been widely used to decrease the invasiveness of the procedure. [18] [19] [20] [21] Before 1980, liver resection was associated with a mortality risk above 10%; 7 however, this rate has decreased dramatically, and it is reported to be <2.5% and even <1% at specialized centers. [22] [23] [24] Despite favorable outcomes, hepatic resection remains a complex procedure associated with significant morbidity. 25 A number of postoperative complications may occur that should always be anticipated, including hemorrhage, pleural effusion, and sub-phrenic infection, biliary tract injury, liver dysfunction, and biliary tract hemorrhage. The most feared life-threatening complication is post-hepatectomy liver failure (PHLF) 26, 27 which occurs following about 10% of resections. 28, 29 PHLF is defined by the International Study Group of Liver Surgery as an increased international normalized ratio and hyperbilirubinemia on or after the fifth postoperative day, thus indicating the inability of the liver to perform its synthetic, excretory, and detoxifying tasks. 30 PHLF accompanied by acute renal failure (ARF) may lead to hepatorenal syndrome. ARF is a complication that is usually reversible, mainly by means of dehydration and diuretics. 31 Bile leakage is another feared complication that occurs in 4-17% of cases.
32
Coagulation disorders can also develop. 33, 34 Infections are predicted following most procedures, with surgical site infections being common. However, intra-abdominal abscesses, postoperative pneumonia and urinary tract infection are also seen, more so in the elderly. 35, 36 Our teaching institution, King Saud University Medical City, has a specialized hepato-pancreaticobiliary (HPB) unit that was established in 2006. Our unit consists of three reputable surgeons trained in advanced HPB and transplant procedures, with a focus on hepatobiliary and oncological diseases. We report our rates of morbidity and mortality following hepatectomy, and our analysis of predicting factors.
PATIENTS AND METHODS
Data were collected from our HPB unit's database for all hepatectomy cases performed at King Saud University Medical City from 2006-2014. Data were collected from hospital medical records, operative records, pathology reports, radiology software, and outpatient clinics. Variables collected were divided into general demographics, preoperative, intraoperative, and postoperative variables, and outcomes. Liver dysfunction was calculated via two common scores: the Schindl score 37 (which is based on total serum bilirubin and lactate, in addition to prothrombin time and encephalopathy), and the 50:50 score 38 (which is based on total serum bilirubin and prothrombin time). Primary outcomes were postoperative morbidity (according to the Clavien-Dindo surgical complication score) 39 and 90-day mortality. Secondary outcomes were all risk factors associated with postoperative morbidity and mortality. A univatiate analysis was done using chi square for nominal variables and the t test or Mann-Whitney U test for continuous variables not normally distributed. Significant variables were then used in a multivariate analysis.
Survival curves were generated to determine disease-specific mortality rates using Kaplan-Meier curves. The log-rank test was used to analyze all collected variables to determine significant risk factors for morbidity after resection and 90-day mortality. Statistical analyses were performed using JMP 11.2.0 software (SAS Institute, Cary, NC).
RESULTS

Indications
Ninety-six liver resections were screened; 19 were excluded due to missing data. Seventy-seven resections were included for further analysis; 56 patients (72.72%) had a malignant etiology, mainly colorectal liver metastases, in 35 patients, and hepatocellular carcinoma in 11 patients (45.45% and 14.29% respectively) ( Table 1) . Four patients had a second resection for recurrences. All patients underwent preoperative assessment of liver volume, and possibility of portal hypertension as clinically indicated.
Baseline characteristics
The mean (standard deviation) age of the 77 patients was 49.1 (15.5) years. Our youngest patient was 14 years, whereas the eldest was 74 years. The percentage of our male patients was slightly higher than that of our female patients (53.3% vs. 46.8%). The mean American Society of Anesthesiologists classification was 2. The median preoperative hospitalization period was 4 days (range: 0-25 days, IQR: 2-8 days). The remaining baseline characteristics and preoperative lab values are in Table 2 . Fifty-six resections were performed for malignant indications. Thirty-seven were Other malignancies* 6 6.5
Benign indications (n=21, 27.3%)
Focal nodular hyperplasia 4 5.2
Hydatid cyst 3 3.9
Simple cyst 3 1.3
Hepatocellular adenoma 1 1.3
Traumatic liver injury 1 1.3
Focal steatosis 2 9.1 Total 77 100
*One resection for each of the following was performed: (1) direct invasion of colorectal cancer into the liver, (2) breast cancer liver metastasis, (3) monophasic synovial sarcoma liver metastasis, (4) hepatoblastoma (5) sarcomatoid tumor and (6) part of extended cholecystectomy for gallbladder cancer. Table 3 . Postoperative outcomes (n=77). 
Overall complications
Missing values 12
All values are number (percent) unless otherwise indicated.
for metastatic lesions (most commonly colorectal liver metastasis, 35 cases), the primary tumor had been resected previously in 29 cases. Extrahepatic synchronous metastasis was documented in 7 patients; 4 of which had pulmonary lesions, the remainders were in peritoneum and colon. Other indications for resection for malignant disease were 11 hepatocellular carcinomas, 2 cases of cholangiocarcinomas, 2 neuroendocrine masses, 1 hepatoblastoma, 1 as part of en bloc resection for colorectal cancer and 1 for a rare hepatic sarcoma. In patients with colorectal liver metastasis (35), 60% received chemotherapy before liver resections (21 cases), with an average of 10 cycles. The median time from the end of chemotherapy to the time of resection was 4.47 months (IQR: 2.53-13.9, range: 1.03-24.2 months). Right portal vein embolization was performed in 6 resections, aiming to improve the future liver residual.
Intraoperative variables
Of the 77 resections, about two-thirds (45/77, 58.4%) were major (i.e., ≥3 segments). Concurrent intra-abdominal surgery was performed in 8 cases, all for either the colon or rectum, and one patient had a breast mass that was excised simultaneously. Epidural anesthesia was used in slightly less than half of the procedures (34/77, 44.2%). A transfusion was needed intraoperatively for 29 patients (37.7%). Our mean total operative time was 5.3 hours (range: 1.7-10.3 hours).
Outcomes
Histologically, the average number of resected lesions was 2 (range: 0-20). The median length of total hospital stay was 12 days, although it ranged from 4-80 days. Complications developed following 30 resections (39.0%), with the majority being Clavien grades I-III. The most frequent complications were sepsis (15/77, 19.5%), blood transfusion (10/77, 3.0%), and organ space infection (8/77, 10.4%) ( Table 3) . Almost half the patients (38/77, 49.4%) exhibited an element of hepatic impairment postoperatively, mostly mild or moderate based on the Schindl liver dysfunction score. 37 Interestingly, when calculating liver dysfunction using the 50:50 criteria, only 12/77 patients (15.6%) had liver dysfunction.
Factors associated with morbidity in a univariate analysis were only the total bilirubin level preoperatively, operative time, extent of the resection (i.e. major resection), use of epidural anesthesia, and postoperative liver dysfunction (calculated by both the Schindl liver dysfunction score and 50:50 criteria). In a multivariate analysis, the Schindl liver dysfunction score showed the strongest correlation (P=.006) with postoperative morbidity. Details of the outcomes and factors that correlated with morbidity and 90-day postoperative mortality are illustrated in Tables 4 and 5 , respectively (All factors shown as Appendices 1 and 2). Factors such as age, gender, body mass index, white blood cell count, hematocrit and several others were not significantly associated with morbidity. The 90-day postoperative mortality was 5.2% (4/77 patients); 3 fulfilled the 50:50 liver dysfunction criteria. Significant predictors were concurrent intra-abdominal surgery, postoperative liver dysfunction, and the development of multiple complications listed in Table 5 . Notably, following the 55 resections performed for malignant indications, histology showed a positive margin in 5 patients (9.1%). 
Overall survival and disease-free survival
DISCUSSION
Liver resection is a major surgical intervention that is the cornerstone of managing various benign and ma- lignant diseases. In Saudi Arabia, data on the indications and outcomes of this procedure are scarce. Therefore, we performed this study to benchmark our experi-ence and identify predictors of morbidity and mortality at our center. We aimed to optimize our patient care in light of our results. As this paper is a retrospective study it suffers all the limitations that apply to this type of study, including missing data, which is apparent in our paper. However from the collected data, the mor-bidity and mortality rates reached 39.0% and 5.2% re-spectively. Compared with data reported by Aloia et al 8 in the National Surgical Quality Improvement Project (NSQIP), our rates are within an acceptably close range. 40 However, the relatively small sample size of our study limits such a comparison, and ongoing prospec-tive data collection is being carried out for future com-parisons and quality improvement.
We found that significant predictors of morbidity were the total bilirubin level preoperatively, operative time, extent of resection, use of epidural anesthesia, and postoperative Schindl score for liver dysfunction. In the literature, it is well established that the opera- tive time and blood loss influence morbidity, whereas epidural anesthesia has a protective role. [41] [42] [43] We think the discrepancies in our data were mainly because of the effect of epidural anesthesia on the operative time, which included within it the anesthesia time.
Significant predictors of 90-day mortality were concurrent intra-abdominal surgery, the postoperative Schindl score for liver dysfunction, the 50:50 liver dysfunction criteria, postoperative blood transfusion, and the development of complications. These data correlate with reported findings, 30 as liver failure is the most commonly reported cause of postoperative mortality following major liver resection. The majority of our liver resections were performed for an oncological indication, which may explain the significant rate of postoperative liver dysfunction. 27 Most of our patients underwent a major liver resection (45 patients, 58.4%), defined as resection of three segments or more. Taking this into consideration when comparing our results to NSQIP data, our morbidity (38.96%) and mortality rates (5.19%) lie in close proximity to their rates for extended resections (31.9% and 5.2% respectively). In our cohort liver dysfunction (49.35%) was the most common complications followed by sepsis (14.98%), and organ space infection (10.39%). In NSQIP data, both organ space collection (4.5-10.9%) and sepsis (5.7-9.6%) were also the most common complications.
In conclusion, liver resection is a safe and feasible option at our center. We attained acceptable preliminary results. However, further care should be taken to note the operative time and postoperative liver failure. Laparoscopic liver surgery is a new emerging modality that has a promising future, and it can be utilized at our institution. Factors that predicted development of complications were elevated total bilirubin level preoperatively, operative time, extent of the resection (i.e. major resection), use of epidural anesthesia and a postoperative need for blood transfusion. The development of postoperative liver dysfunction correlated with 90-day mortality in our sample (P<.0001). The relatively small number of indications for resection, which decreases the variety of risk factors and our inability to derive statistical inferences is a major limitation of the study. Additionally, only a handful of cases were performed laparoscopically, which limits the statistical analysis of that form of surgery. 
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